Scientists Warn Silicon Valley Biohackers Spread Unverified Anti-Aging Regimens to Millions
Updated
Updated · dongascience.com · Jun 17
Scientists Warn Silicon Valley Biohackers Spread Unverified Anti-Aging Regimens to Millions
1 articles · Updated · dongascience.com · Jun 17
Summary
Nature’s June 16 feature said billionaire-backed anti-aging biohacking is spilling from Silicon Valley into the public despite no proven therapy that directly slows aging to extend lifespan.
Bryan Johnson’s regimen illustrates the concern: he began taking rapamycin in 2019 after mouse studies suggested up to 60% longer lifespans, then stopped last September after infections, high blood sugar and other side effects.
Peter Thiel’s past use of human growth hormone, plus growing interest in methylene blue, nicotine pouches and ketone supplements, has widened the trend beyond one high-profile experiment.
Scientists say some ideas have biological plausibility but lack human clinical-trial evidence, and they warn personal protocols are becoming public benchmarks before even basic biomarkers are measured.
Experts argue the real gap is research: large trials involving thousands are still missing even as vast longevity funding flows into self-experimentation and consumer hype.
As billionaires biohack their bodies, are their public experiments a reckless trend or the future of medicine?
Could approving a dog life-extension drug finally unlock legitimate anti-aging medicine for humans?
Silicon Valley’s $610 Billion Longevity Craze: Hype, Science, and the Future of Healthy Aging
Overview
The Silicon Valley longevity craze has sparked a prominent biohacking movement, with wealthy tech executives dedicating vast resources to anti-aging regimens. At the center is Bryan Johnson, who spends $2 million a year on supplements, treatments, and expert consultants, aiming to make his years as vital as possible. His strict daily routine includes over 100 supplements, early meals, and constant tracking of his body's health markers. This trend highlights both the growing fascination with extending life and the intense, sometimes controversial, efforts by industry leaders to push the boundaries of human vitality.